FUMAGALLI, LAURA
FUMAGALLI, LAURA
Dipartimento di Scienze Farmaceutiche
Unraveling the parahormetic mechanism underlying the health-protecting effects of grapeseed procyanidins
2024 G. Baron, A. Altomare, L. Della Vedova, F. Gado, O. Quagliano, S. Casati, N. Tosi, L. Bresciani, D. Del Rio, G. Roda, A. D'Amato, C. Lammi, A. Macorano, S. Vittorio, G. Vistoli, L. Fumagalli, M. Carini, A. Leone, M. Marino, C. Del Bo’, G. Miotto, F. Ursini, P. Morazzoni, G. Aldini
Evaluation of in vitro SARS-CoV-2 inactivation by a new quaternary ammonium compound: Bromiphen bromide
2023 S. Strizzi, G. Cappelletti, M. Biasin, A. Artasensi, L. Fumagalli, A. Casiraghi
A Novel Chromatographic Method to Assess the Binding Ability towards Dicarbonyls
2023 A. Artasensi, E. Salina, L. Fumagalli, L. Regazzoni
Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options
2023 A. Artasensi, A. Mazzolari, A. Pedretti, G. Vistoli, L. Fumagalli
Chemoenzymatic approach towards the synthesis of the antitumor and antileishmanial marine metabolite (+)-Harzialactone A via the stereoselective, biocatalyzed reduction of a prochiral ketone
2023 A. Artasensi, I. Bassanini, E. E Ferrandi, L. Feni, G. Vistoli, L. Fumagalli, R. Gandolfi
Stable isotopic labelling of β-sitosteryl ferulate for use as analytical tool
2022 S. Mazzotta, G. Baron, L. Fumagalli
Discovery of a potent and highly selective Dipeptidyl Peptidase IV and Carbonic Anhydrase inhibitor as “antidiabesity” agent based on repurposing and morphing of WB-4101
2022 A. Artasensi, A. Angeli, C. Lammi, C. Bollati, S. Gervasoni, G. Baron, R. Matucci, C. Supuran, G. Vistoli, L. Fumagalli
Utilization of diverse organophosphorus pollutants by marine bacteria
2022 D. Despotovi('(c)), E. Aharon, O. Trofimyuk, A. Dubovetskyi, K. Phaneendra Cherukuri, Y. Ashani, O. Eliason, M. Sperfeld, H. Leader, A. Castelli, L. Fumagalli, A. Savidor, Y. Levin, L.M. Longo, E. Segev, D.S. Tawfik
Cyclo(His-Pro) Exerts Protective Carbonyl Quenching Effects through Its Open Histidine Containing Dipeptides
2022 L. Regazzoni, L. Fumagalli, A. Artasensi, S. Gervasoni, E. Gilardoni, A. Mazzolari, G. Aldini, G. Vistoli
Novel potential DPP IV/CA II inhibitors for treatment of type 2 diabetes
2021 A. Artasensi, A. Angeli, C. Lammi, C. Supuran, G. Vistoli, L. Fumagalli
Quinone Methide-Based Organophosphate Hydrolases Inhibitors : Trans Proximity Labelers versus Cis Labeling Activity-Based Probes
2021 A. Dubovetskyi, K.P. Cherukuri, Y. Ashani, A. Meshcheriakova, E. Reuveny, G. Ben-Nissan, M. Sharon, L. Fumagalli, D.S. Tawfik
Novel potential multitarget compounds for treatment of Type 2 Diabetes
2021 A. Artasensi, A. Angeli, C. Lammi, C. Supuran, G. Vistoli, L. Fumagalli
Back to basics : choosing the appropriate surface disinfectant
2021 A. Artasensi, S. Mazzotta, L. Fumagalli
Candida albicans Biofilm Inhibition by Two Vaccinium macrocarpon (Cranberry) Urinary Metabolites: 5-(3',4'-{DihydroxyPhenyl})-gamma-Valerolactone and 4-Hydroxybenzoic Acid
2021 E. Ottaviano, G. Baron, L. Fumagalli, J. Leite, E.A. Colombo, A. Artasensi, G. Aldini, E. Borghi
The VEGA suite of programs: a versatile platform for cheminformatics and drug design projects
2021 A. Pedretti, A. Mazzolari, S. Gervasoni, L. Fumagalli, G. Vistoli
Analytical Profile and Antioxidant and Anti-Inflammatory Activities of the Enriched Polyphenol Fractions Isolated from Bergamot Fruit and Leave
2021 G. Baron, A.A. Altomare, M.H.A. Mol, J. Leite Garcia, C. Correa, A. Raucci, L. Mancinelli, S. Mazzotta, L. Fumagalli, G. Trunfio, L. Tucci, E. Lombardo, D. Malara, E. Janda, V. Mollace, M. Carini, E. Bombardelli, G. Aldini
Regioselective, Efficient and Sustainable Bromination Process for the Synthesis of the Antimicrobial Agent Bromiphen Bromide
2021 A. Artasensi, A. Pedretti, G. Vistoli, L. Fumagalli
(Z)-5-(3′,4′-Bis(benzyloxy)benzylidene)furan-2(5H)-one
2021 A. Artasensi, G. Baron, G. Vistoli, G. Aldini, L. Fumagalli
COMPOUNDS HAVING PRESERVATIVE, ANTIMICROBIAL AND ANTISEPTIC ACTIVITY
2020 G. Aldini, L. Regazzoni, C. Picozzi, M. Carini, L. Fumagalli, G. Vistoli
Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs
2020 A. Artasensi, A. Pedretti, G. Vistoli, L. Fumagalli